BeOne Medicines AG (ONC)

BeOne Medicines AG (ONC) is a healthcare company (biotechnology) based in Switzerland. The share price is $410.15, down 0.28% on the day, which values the company at $46.85B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$410.15−0.28% today
Market value
$46.85B
P/E ratio
52.6×last 12 months
Forward P/E
38.3×
Funk Score
71/100
Against its own history
Well above its usual priceusual price $273.35
200-week average
$245.6567% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

BeOne Medicines AG in more detail

ONC trades at 52.6× its last twelve months' earnings, 38.3× next year's expected earnings, 7.1× sales. Measured against its own history, the price is 50% above what its usual multiples would imply ($273.35) — well above its usual price. It sits 67% above its 200-week average of $245.65.

Over the last five fiscal years BeOne Medicines AG has compounded revenue 76.8% a year. Its Funk Score is 71 out of 100 (financial strength 8.2, profitability 6.2, growth 10.0, value 4.1, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Share count keeps rising.

6 of the superinvestors tracked here hold ONC, including Julian and Felix Baker (12.6% of the portfolio), Primecap team (1.1% of the portfolio), Ken Griffin (0.2% of the portfolio).

Superinvestors holding ONC

6 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ONC vs WAT (BeOne Medicines AG vs Waters)ONC vs NTRA (BeOne Medicines AG vs Natera)ONC vs IQV (BeOne Medicines AG vs IQVIA Holdings)ONC vs TEVA (BeOne Medicines AG vs Teva Pharmaceutical Industries)ONC vs A (BeOne Medicines AG vs Agilent Technologies)

All health care companies by market valueLargest companies in SwitzerlandAll stocks A–Z

BeOne Medicines AG (ONC): questions and answers

What is ONC's P/E ratio?

BeOne Medicines AG trades at 52.6× its last twelve months' earnings and 38.3× next year's expected earnings.

What is ONC's PEG ratio?

BeOne Medicines AG's PEG ratio is 0.73 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is BeOne Medicines AG's market cap?

BeOne Medicines AG is valued at $46.85B at a share price of $410.15.

Is ONC overvalued or undervalued?

Against its own history, ONC is well above its usual price: the price is 50% above the $273.35 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ONC above its 200-week moving average?

Yes. ONC is 67.0% above its 200-week average of $245.65. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is BeOne Medicines AG growing?

Over the last five fiscal years BeOne Medicines AG's revenue grew 76.8% a year; over ten years revenue grew 89.8% a year.

Cite this page

Funkfolio, “BeOne Medicines AG (ONC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ONC

Underlying data: Yahoo Finance; company filings with the SEC.